Atlas Trials

TRC105 for Recurrent Glioblastoma

Clinical trial NCT01778530 · TERMINATED

Trial details

NCT number
NCT01778530
Sponsor
National Cancer Institute (NCI)
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Glioblastoma Multiforme
Start date
2012-12-01
Primary completion
2014-02-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.